Palantir’s software, introduced to help NHS England improve care delivery and reduce delays, is facing resistance from staff over concerns about ethics, privacy, and trust, according to recent reports.
Healthcare workers across the system have been quoted as saying that some colleagues are actively boycotting Palantir’s Federated Data Platform, part of a £330 million contract awarded in 2023 to integrate NHS data into a single searchable system aimed at addressing care backlogs. While the platform is intended to streamline access to information, its adoption has been uneven.
Staff Resistance and Ethical Concerns
NHS staff, both clinical and non-clinical, have raised objections to using the system, citing discomfort with the company’s role and broader concerns about data use. Some care boards have delayed implementation due to reluctance among employees, while the British Medical Association has called on doctors to stop using the platform.
According to accounts reported this week, some staff have described the system in stark terms, with one official reportedly calling Palantir “ethically bankrupt” and refusing to use the software. Others said colleagues were deliberately slowing their work when required to engage with the platform. Another staff member said the system did not offer meaningful improvements and that many preferred to work around it, despite feeling uneasy when using it. One individual described a strong emotional response, saying the experience of logging into the system made them feel ill.
FCRF Launches Premier CISO Certification Amid Rising Demand for Cybersecurity Leadership
Privacy Fears and Political Pressure
Concerns about Palantir’s involvement in the NHS predate the awarding of the contract. Officials and members of the public have pointed to the company’s relationship with the United States government as a source of unease.
More recently, opposition has intensified over Palantir’s work with Immigration and Customs Enforcement on deportation efforts under the Trump administration. These concerns have contributed to broader skepticism about the handling of patient data and the transparency of the contract process.
Reports indicate that some UK government officials are now considering ending the agreement by invoking a break clause, citing a lack of clarity around how the contract was originally awarded. Members of Parliament, however, have pushed back on claims that the effort is ideologically driven, arguing instead that scrutiny is focused on procurement and data governance.
Contract Expansion Despite Backlash
Despite the controversy, Palantir’s presence within UK government systems appears to be expanding. The Financial Conduct Authority has recently signed a three-month trial contract with the company to analyze financial complaints data.
This development follows other agreements, including a follow-on data and software arrangement with the Ministry of Defence, details of which were published earlier this year. The expansion comes even as the government has stated its intention to strengthen technological sovereignty in its procurement decisions.
The evolving situation highlights the tension between efforts to modernize public services through data integration and ongoing concerns about privacy, oversight, and trust in the institutions managing sensitive information.
